4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000019
Options or other derivatives
- SVP, Chief Financial Officer acquired 244,052 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Branning Todd P. · SVP, Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-01-22 | Grant or award : show line 1 in the form Stock Option | +163,666 | 163,666 | D |
| 2019-01-22 | Grant or award : show line 2 in the form Restricted Stock Units | +80,386 | 80,386 | D |
Loading xslF345X03/wf-form4_154836993308270.xml…